DB18579InvestigationalGene Therapies
ETX101 is a non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene.
- Also known as
- non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene
- Code names
- ETX-101
What you can answer from here — as of April 23, 2025
Which companies are running trials of ETX101, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account